Loss of Anterior Gradient-2 expression is an independent prognostic factor in colorectal carcinomas

European Journal of Cancer

Volumn 50, Issue 10, 2014, Pages 1722-1730

  Riener, Marc Oliver ^a   Thiesler, Thore ^b   Hellerbrand, Claus ^c   Amann, Thomas ^c   Cathomas, Gieri ^d   Fritzsche, Florian Rudolph ^e   Dahl, Edgar ^f   Bahra, Marcus ^g   Weichert, Wilko ^h   Terracciano, Luigi ⁱ   Kristiansen, Glen ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^g CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^h UNIVERSITY OF HEIDELBERG   (Germany)

ⁱ UNIVERSITY OF BASEL   (Switzerland)

Author keywords

AGR2; Colorectal carcinoma; Immunohistochemistry; Prognosis

Indexed keywords

ANTERIOR GRADIENT 2 PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CANCER TISSUE; CARCINOMA CELL LINE; COLON MUCOSA; COLORECTAL CANCER CELL LINE; COLORECTAL CARCINOMA; CORRELATIONAL STUDY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE CELL; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; TUMOR LOCALIZATION;

AGR2; COLORECTAL CARCINOMA; IMMUNOHISTOCHEMISTRY; PROGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CACO-2 CELLS; CARCINOMA; CHI-SQUARE DISTRIBUTION; COLORECTAL NEOPLASMS; DOWN-REGULATION; HCT116 CELLS; HT29 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; PROTEINS; RISK FACTORS; RNA INTERFERENCE; TIME FACTORS; TRANSFECTION; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84901760268     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2014.04.012     Document Type: Article

References (35)

1. A. Jemal, R. Siegel, J. Xu, and E. Ward Cancer statistics, 2010 CA Cancer J Clin 60 5 2010 277 300
2. S. Aggarwal, and E. Chu Current therapies for advanced colorectal cancer Oncology (Williston Park) 19 5 2005 589 595
3. W. Weichert, C. Denkert, M. Burkhardt, T. Gansukh, J. Bellach, and P. Altevogt et al. Cytoplasmic CD24 expression in colorectal cancer independently correlates with shortened patient survival Clin Cancer Res 11 18 2005 6574 6581
4. W. Weichert, T. Knosel, J. Bellach, M. Dietel, and G. Kristiansen ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival J Clin Pathol 57 11 2004 1160 1164
5. W. Weichert, G. Kristiansen, M. Schmidt, V. Gekeler, A. Noske, and S. Niesporek et al. Polo-like kinase 1 expression is a prognostic factor in human colon cancer World J Gastroenterol 11 36 2005 5644 5650
6. W. Weichert, A. Roske, S. Niesporek, A. Noske, A.C. Buckendahl, and M. Dietel et al. Class I histone deacetylase expression has independent prognostic impact in human colorectal cancer: specific role of class I histone deacetylases in vitro and in vivo Clin Cancer Res 14 6 2008 1669 1677
7. G.C. Fletcher, S. Patel, K. Tyson, P.J. Adam, M. Schenker, and J.A. Loader et al. hAG-2 and hAG-3, human homologues of genes involved in differentiation, are associated with oestrogen receptor-positive breast tumours and interact with metastasis gene C4.4a and dystroglycan Br J Cancer 88 2003 579 585
8. T. Komiya, Y. Tanigawa, and S. Hirohashi Cloning of the gene gob-4, which is expressed in intestinal goblet cells in mice Biochim Biophys Acta 1444 3 1999 434 438
9. Z. Wang, Y. Hao, and A.W. Lowe The adenocarcinoma-associated antigen, AGR2, promotes tumor growth, cell migration, and cellular transformation Cancer Res 68 2 2008 492 497
10. G. Kristiansen, C. Pilarsky, C. Wissmann, S. Kaiser, T. Bruemmendorf, and S. Roepcke et al. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival J Pathol 205 3 2005 359 376
11. J.S. Zhang, A. Gong, J.C. Cheville, D.I. Smith, and C.Y. Young AGR2, an androgen-inducible secretory protein overexpressed in prostate cancer Genes Chromosomes Cancer 43 3 2005 249 259
12. F.R. Fritzsche, E. Dahl, S. Pahl, M. Burkhardt, J. Luo, and E. Mayordomo et al. Prognostic relevance of AGR2 expression in breast cancer Clin Cancer Res 12 6 2006 1728 1734
13. F.R. Fritzsche, E. Dahl, A. Dankof, M. Burkhardt, S. Pahl, and I. Petersen et al. Expression of AGR2 in non small cell lung cancer Histol Histopathol 22 7 2007 703 708
14. H.E. Innes, D. Liu, R. Barraclough, M.P. Davies, P.A. O'Neill, and A. Platt-Higgins et al. Significance of the metastasis-inducing protein AGR2 for outcome in hormonally treated breast cancer patients Br J Cancer 94 7 2006 1057 1065
15. C.A. Iacobuzio-Donahue, A. Maitra, M. Olsen, A.W. Lowe, N.T. van Heek, and C. Rosty et al. Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays Am J Pathol 162 4 2003 1151 1162
16. E. Missiaglia, E. Blaveri, B. Terris, Y.H. Wang, E. Costello, and J.P. Neoptolemos et al. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis Int J Cancer 112 1 2004 100 112
17. M.O. Riener, C. Pilarsky, J. Gerhardt, R. Grutzmann, F.R. Fritzsche, and M. Bahra et al. Prognostic significance of AGR2 in pancreatic ductal adenocarcinoma Histol Histopathol 24 9 2009 1121 1128
18. D.A. Smirnov, D.R. Zweitzig, B.W. Foulk, M.C. Miller, G.V. Doyle, and K.J. Pienta et al. Global gene expression profiling of circulating tumor cells Cancer Res 65 12 2005 4993 4997
19. S.W. Park, G. Zhen, C. Verhaeghe, Y. Nakagami, L.T. Nguyenvu, and A.J. Barczak et al. The protein disulfide isomerase AGR2 is essential for production of intestinal mucus Proc Natl Acad Sci U S A 106 17 2009 6950 6955
20. F. Zhao, R. Edwards, D. Dizon, K. Afrasiabi, J.R. Mastroianni, and M. Geyfman et al. Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2-/- mice Dev Biol 338 2 2010 270 279
21. S. Lee, S. Bang, K. Song, and I. Lee Differential expression in normal-adenoma-carcinoma sequence suggests complex molecular carcinogenesis in colon Oncol Rep 16 4 2006 747 754
22. G. Kristiansen, K. Schluns, Y. Yongwei, C. Denkert, M. Dietel, and I. Petersen CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients Br J Cancer 88 2 2003 231 236
23. F. Bataille, G. Rogler, K. Modes, I. Poser, M. Schuierer, and W. Dietmaier et al. Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-catenin Lab Invest 85 1 2005 124 136
24. C. Hellerbrand, E. Bumes, F. Bataille, W. Dietmaier, R. Massoumi, and A.K. Bosserhoff Reduced expression of CYLD in human colon and hepatocellular carcinomas Carcinogenesis 28 1 2007 21 27
25. D. Liu, P.S. Rudland, D.R. Sibson, A. Platt-Higgins, and R. Barraclough Human homologue of cement gland protein, a novel metastasis inducer associated with breast carcinomas Cancer Res 65 9 2005 3796 3805
26. F. Aberger, G. Weidinger, H. Grunz, and K. Richter Anterior specification of embryonic ectoderm: the role of the Xenopus cement gland-specific gene XAG-2 Mech Dev 72 1-2 1998 115 130
27. W. Zheng, P. Rosenstiel, K. Huse, C. Sina, R. Valentonyte, and N. Mah et al. Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease Genes Immun 7 1 2006 11 18
28. V. Ramachandran, T. Arumugam, H. Wang, and C.D. Logsdon Anterior gradient 2 is expressed and secreted during the development of pancreatic cancer and promotes cancer cell survival Cancer Res 68 19 2008 7811 7818
29. A. Gupta, D. Wodziak, M. Tun, D.M. Bouley, and A.W. Lowe Loss of anterior gradient 2 (Agr2) expression results in hyperplasia and defective lineage maturation in the murine stomach J Biol Chem 288 6 2013 4321 4333
30. S. Thomson, F. Petti, I. Sujka-Kwok, P. Mercado, J. Bean, and M. Monaghan et al. A systems view of epithelial-mesenchymal transition signaling states Clin Exp Metastasis 28 2 2011 137 155
31. D.L. Barraclough, A. Platt-Higgins, S. de Silva Rudland, R. Barraclough, J. Winstanley, and C.R. West The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients Am J Pathol 175 5 2009 1848 1857
32. H. Zhu, D.C. Lam, K.C. Han, V.P. Tin, W.S. Suen, and E. Wang et al. High resolution analysis of genomic aberrations by metaphase and array comparative genomic hybridization identifies candidate tumour genes in lung cancer cell lines Cancer Lett 245 1-2 2007 303 314
33. E.L. Maresh, V. Mah, M. Alavi, S. Horvath, L. Bagryanova, and E.S. Liebeskind et al. Differential expression of anterior gradient gene AGR2 in prostate cancer BMC Cancer 10 2010 680
34. E. Pohler, A.L. Craig, J. Cotton, L. Lawrie, J.F. Dillon, and P. Ross et al. The Barrett's antigen anterior gradient-2 silences the p53 transcriptional response to DNA damage Mol Cell Proteomics 3 6 2004 534 547
35. R. Chen, S. Pan, X. Duan, B.H. Nelson, R.A. Sahota, and S. de Rham et al. Elevated level of anterior gradient-2 in pancreatic juice from patients with pre-malignant pancreatic neoplasia Mol Cancer 9 2010 149